doxorubicin

You have access
The Role of Metoprolol and Enalapril in the Prevention of Doxorubicin-induced Cardiotoxicity in Lymphoma Patients
PETER GEORGAKOPOULOS, MICHAEL KYRIAKIDIS, ANASTASIA PERPINIA, APOSTOLOS KARAVIDAS, STELIOS ZIMERAS, NIKOLAOS MAMALIS, MAROUSA KOUVELA and ANDRIANI CHARPIDOU

Anticancer Research October 2019, 39 (10) 5703-5707; DOI: https://doi.org/10.21873/anticanres.13769
You have access
Eribulin Suppressed Cisplatinum- and Doxorubicin-resistant Recurrent Lung Metastatic Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
TASUKU KIYUNA, YASUNORI TOME, KENTARO MIYAKE, TAKASHI MURAKAMI, HIROMICHI OSHIRO, KENTARO IGARASHI, KEI KAWAGUCHI, JOHN HSU, MANISH SINGH, YUNFENG LI, SCOTT NELSON, MICHAEL BOUVET, SHREE RAM SINGH, FUMINORI KANAYA and ROBERT M. HOFFMAN

Anticancer Research September 2019, 39 (9) 4775-4779; DOI: https://doi.org/10.21873/anticanres.13661
You have access
Selenoesters and Selenoanhydrides as Novel Agents Against Resistant Breast Cancer
ANDREA CSONKA, ANNAMÁRIA KINCSES, MÁRTA NOVÉ, ZSÓFIA VADAS, CARMEN SANMARTÍN, ENRIQUE DOMÍNGUEZ-ÁLVAREZ and GABRIELLA SPENGLER

Anticancer Research July 2019, 39 (7) 3777-3783; DOI: https://doi.org/10.21873/anticanres.13526
You have access
Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood–Brain Barrier
BO YUAN, YARONG ZHAO, SHIYAN DONG, YATING SUN, FEI HAO, JING XIE, LESHENG TENG, ROBERT J. LEE, YAOWEN FU and YE BI

Anticancer Research January 2019, 39 (1) 237-243; DOI: https://doi.org/10.21873/anticanres.13103
You have access
No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis
VIRGINIE LARBRE, MOHAMMAD ALYAMI, FREDERIC MERCIER, NICOLAS VANTARD, ISABELLE BONNEFOY, MARIE-AGNÈS OPSOMER, LAURENT VILLENEUVE, NAOUAL BAKRIN, CATHERINE RIOUFOL, OLIVIER GLEHEN and VAHAN KEPENEKIAN

Anticancer Research December 2018, 38 (12) 6869-6875; DOI: https://doi.org/10.21873/anticanres.13062
You have access
Oral Recombinant Methioninase Combined with Caffeine and Doxorubicin Induced Regression of a Doxorubicin-resistant Synovial Sarcoma in a PDOX Mouse Model
TAKASHI HIGUCHI, KEI KAWAGUCHI, KENTARO MIYAKE, QINGHONG HAN, YUYING TAN, HIROMICHI OSHIRO, NORIHIKO SUGISAWA, ZHIYING ZHANG, SAHAR RAZMJOOEI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, SANT P. CHAWLA, ARUN S. SINGH, FREDERICK C. EILBER, SHREE RAM SINGH, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN

Anticancer Research October 2018, 38 (10) 5639-5644; DOI: https://doi.org/10.21873/anticanres.12899
You have access
Chloroquine Used in Combination with Chemotherapy Synergistically Suppresses Growth and Angiogenesis In Vitro and In Vivo
EBRU GUREL-GUREVIN, HULYA TUBA KIYAN, OSMAN BEHZAT BURAK ESENER, SEYMA AYDINLIK, AYCA UVEZ, ENGIN ULUKAYA, KONSTANTINOS DIMAS and ELIF ILKAY ARMUTAK

Anticancer Research July 2018, 38 (7) 4011-4020; DOI: https://doi.org/10.21873/anticanres.12689
You have access
Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) via Endoscopical Microcatheter System
VERIA KHOSRAWIPOUR, AGATA MIKOLAJCZYK, JUSTYNA SCHUBERT and TANJA KHOSRAWIPOUR

Anticancer Research June 2018, 38 (6) 3447-3452; DOI: https://doi.org/10.21873/anticanres.12613
You have access
(–)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways
HANA SATONAKA, KUMIKI ISHIDA, MIHO TAKAI, RYOJI KOIDE, RYOTA SHIGEMASA, JUN UEYAMA, TETSUYA ISHIKAWA, KAZUHIKO HAYASHI, HIDEMI GOTO and SHINYA WAKUSAWA

Anticancer Research November 2017, 37 (11) 6071-6077;
You have access
Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma
ETSUKO KAMATA, TERUYA KAWAMOTO, TAKESHI UEHA, HITOMI HARA, NAOMASA FUKASE, MASAYA MINODA, MASAYUKI MORISHITA, TOSHIYUKI TAKEMORI, SHUICHI FUJIWARA, KOTARO NISHIDA, RYOSUKE KURODA, MASAHIRO KUROSAKA and TOSHIHIRO AKISUE

Anticancer Research November 2017, 37 (11) 6097-6106;

Main menu

User menu

Search

doxorubicin

Pages